Viwit Pharmaceuticals

Viwit Pharmaceuticals, established in 2006, is a dynamic, research-driven pharmaceutical and healthcare company. It focuses on developing, manufacturing, and marketing innovative products across Finished Dosage Formulations, Active Pharmaceutical Ingredients (APIs), and Fine Chemicals. The company leverages its core technologies to deliver solutions aimed at enhancing customer success and promoting healthier living. Viwit Pharmaceuticals operates with a clear mission: "Innovation for a better life," underpinned by a culture of integrity, respect, collaboration, and excellence. This foundational approach guides its strategic direction and operational execution within the competitive pharmaceutical landscape.

The company's operational infrastructure includes six subsidiaries, featuring two integrated R&D centers and three cGMP-certified production facilities. Spanning a significant land area of 199,000 square meters, Viwit Pharmaceuticals employs nearly 500 dedicated staff members, including over 150 scientists holding advanced degrees. Its production sites adhere strictly to cGMP and ICH quality systems, holding certifications from cFDA (Chinese GMP 2010), ISO9000:2008, Mexican COFEPRIS, and the World Health Organization. This robust framework ensures high standards in manufacturing and quality control. For insights into the personnel driving these advancements, one can explore Meet Viwit Pharmaceuticals's team.

Viwit Pharmaceuticals is strategically positioned to become a global leader in the development and commercialization of specialty, value-added pharmaceutical products. The company creates value for customers, employees, shareholders, and society, contributing to a healthier world. Operating in a competitive market with entities like STA Pharmaceutical and Cambrex, Viwit Pharmaceuticals emphasizes technological innovation and global reach to achieve its objectives and serve a broader patient population.